FrancophonIA/ELRC3.0 huggingface dataset:
English: Although the Member States agreed that 1 mg Glimepirida Parke-Davis was bioequivalent to 1 mg Amaryl, concerns remained over whether a bioequivalence study should have been carried out with the highest strength, 4 mg, to show bioequivalence for Glimepirida Parke-Davis 2, 3 and 4 mg with Amaryl at the corresponding doses.
Danish: Skønt medlemsstaterne tilsluttede sig, at Glimepirida Parke-Davis 1 mg var bioækvivalent med Amaryl 1 mg, var der betænkelighed med hensyn til, hvorvidt der burde have været udført en bioækvivalensundersøgelse med den højeste styrke, 4 mg, for at påvise bioækvivalensen af Glimepirida Parke-Davis 2, 3 og 4 mg med Amaryl i samme styrker.
English: Parke-Davis submitted an application for Glimepirida Parke-Davis (1, 2, 3 and 4 mg tablets) to the Portuguese medicines regulatory agency for a decentralised procedure.
Danish: Parke-Davis indgav en ansøgning om markedsføringstilladelse for Glimepirida Parke-Davis (tabletter, 1 mg, 2 mg, 3 mg og 4 mg) til den portugisiske lægemiddelkontrolmyndighed ved en decentral procedure.
English: The grounds for the referral were concerns over the approach used to demonstrate that Glimepirida Parke-Davis 2, 3 and 4 mg are ‘bioequivalent' to Amaryl at the corresponding doses.
Danish: Begrundelsen for indbringelsen var betænkelighed ved den metode, der var anvendt til at påvise, at Glimepirida Parke-Davis, 2, 3 og 4 mg, var bioækvivalente med samme styrker af Amaryl.
English: Annex I
Danish: Bilag I
English: List of the names, pharmaceutical forms, strength of the medicinal products, routes of administration, marketing authorisation holders in the Member States
Danish: Fortegnelse over lægemidlernes navne, lægemiddelformer, styrke, indgivelsesveje, indehavere af markedsføringstilladelser i medlemsstaterne
English: * Strength applicable for all countries After reconstitution, 1 dose (0.5 ml) contains: Live attenuated measles virus (Schwarz strain)
Danish: * Styrke gældende for alle lande Efter rekonstitution indeholder 1 dosis (0,5 ml): Levende, svækket mæslingevirus (Schwarz-stamme)
English: not less than 103.7 CCID50
Danish: ikke mindre end 103,7 CCID50
English: not less than 103.0 CCID50
Danish: ikke mindre end 103,0 CCID50
English: Live attenuated rubella virus (Wistar RA 27/3 strain)
Danish: Levende, svækket rubellavirus (Wistar RA 27/3-stamme)
English: GSK d.o.o., Ljubljana, Knezov štradon 90, 1000 Ljubljana
Danish: Slovenien GSK d.o.o., Ljubljana, Knezov štradon 90, 1000 Ljubljana Slovenia
English: GlaxoSmithKline AB, Box 516, 169 29 Solna Sweden
Danish: GlaxoSmithKline AB, Box 516, 169 29 Solna
English: Live attenuated mumps virus (RIT 4385 strain, derived from Jeryl Lynn strain)
Danish: Levende, svækket fåresygevirus (RIT 4385 - afledt af Jeryl Lynn-stamme)
English: Goštauto 40A LT-01112, Vilnius Lithuania
Danish: LT-01112, Vilnius Lithuania
English: 9GS
Danish: KG
English: GlaxoSmithKline GmbH & Co. KG
Danish: GlaxoSmithKline GmbH & Co.
English: Albert Schweitzer-Gasse 6 A-1140 Wien
Danish: GlaxoSmithKline Pharma GmbH Albert Schweitzer-Gasse 6 A-1140 Wien
English: GlaxoSmithKline Pharma A/S
Danish: GlaxoSmithKline Pharma A/S Nykær 68
English: GlaxoSmithKline AEBE 266 Kifisias avenue 152 32 Halandri Greece
Danish: Grækenland GlaxoSmithKline AEBE 266 Kifisias avenue
English: Slovenia
Danish: Slovakiet
English: United Kingdom SmithKline Beecham plc 980 Great West Road,
Danish: Storbritannien SmithKline Beecham plc 980 Great West Road, Brentford, Middlesex TW8 9GS United Kingdom
English: UAB „GlaxoSmithKline Lietuva“
Danish: UAB „GlaxoSmithKline Lietuva“ Goštauto 40A
English: Measles, mumps, and rubella vaccine (live)
Danish: Priorix powder and solvent for solution for injection in a prefilled syringe Measles, mumps, and rubella vaccine (live)
English: Luxembourg GlaxoSmithKline Biologicals s.a.
Danish: Luxembourg GlaxoSmithKline Biologicals s.a. Rue de l'Institut, 89
English: Powder and solvent for suspension for injection
Danish: Subcutaneous use Pulver og solvens til injektionsvæske, opløsning
English: Slovak Republic GlaxoSmithKline Biologicals s.a.
Danish: Bulgarien GlaxoSmithKline Biologicals s.a. Rue de l'Institut, 89
English: Powder in vials and solvent in prefilled-syringes for solution for injection
Danish: Pulver og solvens til injektionsvæske, opløsning i fyldt injektionssprøjte
English: Rue de l'Institut, 89
Danish: GlaxoSmithKline Biologicals SA Rue de l'Institut 89
English: This summary was last updated in 05-2011.
Danish: Dette sammendrag blev sidst ajourført i 05-2011.
English: The European Commission granted a marketing authorisation valid throughout the European Union for Ovitrelle on 2 February 2001.
Danish: Europa-Kommissionen udstedte en markedsføringstilladelse med gyldighed i hele Den Europæiske Union for Ovitrelle den 2. februar 2001.
English: The full EPAR for Ovitrelle can be found on the Agency's website: ema.europa.eu/Find medicine/Human medicines/European Public Assessment Reports.
Danish: Den fuldstændige EPAR for Ovitrelle findes på agenturets websted: ema.europa.eu/Find medicine/Human medicines/European Public Assessment Reports.
English: This is a summary of the European public assessment report (EPAR) for Ovitrelle.
Danish: Dette dokument er et sammendrag af den europæiske offentlige vurderingsrapport (EPAR) for Ovitrelle.
English: Ovitrelle is given by injection under the skin.
Danish: Ovitrelle gives ved injektion under huden.
English: The patient or their partner may carry out the injection if they have been trained and have access to expert advice.
Danish: Patienten eller hendes partner kan selv foretage indsprøjtningerne, hvis de har fået vist teknikken og har adgang til ekspertrådgivning.
English: Other information about Ovitrelle
Danish: Andre oplysninger om Ovitrelle
English: Ovitrelle has mainly been studied in women undergoing fertility treatment (1,140 patients).
Danish: Ovitrelle blev primært undersøgt hos kvinder i fertilitetsbehandling (1 140 patienter).
English: One study was also carried out in women who could not ovulate.
Danish: Der blev desuden gennemført en undersøgelse af kvinder, der ikke kan få ægløsning.
English: It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the medicine to reach its opinion in favour of granting a marketing authorisation and its recommendations on the conditions of use for Ovitrelle.
Danish: Det forklarer, hvordan Udvalget for Lægemidler til Mennesker (CHMP) vurderede lægemidlet og nåede frem til sin udtalelse til fordel for udstedelse af en markedsføringstilladelse og til sine anbefalinger om anvendelsesbetingelserne for Ovitrelle.
English: It must not be used when a response cannot be obtained (such as in ovarian failure).
Danish: Det må ikke anvendes, når der ikke kan opnås nogen virkning (som ved ovariesvigt).
English: In anovulatory women, ovulation was seen in 92% of the women treated with Ovitrelle.
Danish: Hos anovulatoriske kvinder iagttoges ægløsning hos 92 % af de kvinder, der blev behandlet med Ovitrelle.
English: The CHMP decided that Ovitrelle's benefits are greater than its risks and recommended that it be given marketing authorisation.
Danish: CHMP besluttede, at fordelene ved Ovitrelle er større end risiciene, og anbefalede udstedelse af markedsføringstilladelse for Ovitrelle.
English: For more information about treatment with Ovitrelle, read the package leaflet (also part of the EPAR) or contact your doctor or pharmacist.
Danish: Hvis du ønsker yderligere oplysninger om behandling med Ovitrelle, kan du læse indlægssedlen (også en del af denne EPAR) eller kontakte din læge eller dit apotek.
English: EPAR summary for the public choriogonadotropin alfa
Danish: EPAR - sammendrag for offentligheden choriogonadotropin alfa
English: Treatment with Ovitrelle should be carried out under the supervision of a doctor who has experience in the treatment of fertility problems.
Danish: Behandling med Ovitrelle bør foretages under opsyn af en læge med erfaring i fertilitetsbehandling.
English: Ovitrelle must also not be used in patients with active thromboembolic disorders (problems with blood clotting).
Danish: Ovitrelle må heller ikke anvendes til patienter med aktive tromboemboliske komplikationer (problemer med blodpropper).
English: Ovitrelle (250 micrograms or 500 micrograms) was compared with the natural hCG hormone that had been extracted from urine.
Danish: Ovitrelle (250 mikrogram eller 500 mikrogram) blev sammenlignet med det naturlige hCG-hormon, der var udvundet af urin.
English: For the full list of restrictions, see the package leaflet.
Danish: Den fuldstændige liste over begrænsningerne fremgår af indlægssedlen.
English: The effectiveness of Ovitrelle was measured by looking at how many eggs were released.
Danish: Virkningen af Ovitrelle blev bedømt på, hvor mange æg der blev løst.
English: The most common side effects with Ovitrelle (seen in between 1 and 10 patients in 100) are reactions at the injection site, headache, tiredness, vomiting, nausea (feeling sick), abdominal pain (stomach ache) and ovarian hyperstimulation syndrome (such as feeling sick, weight gain and diarrhoea).
Danish: De hyppigste bivirkninger ved Ovitrelle (som optræder hos mellem 1 og 10 patienter ud af 100) er reaktioner på injektionsstedet, hovedpine, træthed, opkastninger, kvalme, mavesmerter og ovarielt hyperstimulationssyndrom (såsom kvalme, vægtøgning og diarré).
English: Ovitrelle should not be used in people who may be hypersensitive (allergic) to choriogonadotropin alfa or any of the other ingredients.
Danish: Ovitrelle må ikke gives til personer, der kan være overfølsomme (allergiske) over for choriogonadotropin alfa eller et af de øvrige indholdsstoffer.
English: Ovitrelle was as effective as urinary hCG in triggering ovulation, and the 250-microgram dose of Ovitrelle was as effective as the 500-microgram dose.
Danish: Ovitrelle var lige så effektivt som hCG fra urin til at fremkalde ægløsning, og en dosering på 250 mikrogram var lige så effektiv som en på 500 mikrogram.
English: The active substance in Ovitrelle, choriogonadotropin alfa, is a copy of the natural hormone human chorionic gonadotropin (hCG), also known as the ‘pregnancy' hormone, which helps to maintain pregnancy.
Danish: Det aktive stof i Ovitrelle, choriogonadotrophin alfa, er en kopi af det naturlige hormon humant choriongonadotrophin (hCG), hvilket også er kendt som ‘graviditets'-hormonet, som hjælper med at opretholde graviditeten.
English: Ovitrelle is a medicine that contains the active substance choriogonadotropin alfa.
Danish: Ovitrelle er et lægemiddel, der indeholder det aktive stof choriogonadotropin alfa.
English: A dose of 250 micrograms is given 24 to 48 hours after the ovaries have produced follicles that are mature enough (eggs ready for ovulation).
Danish: Der gives en dosis på 250 mikrogram 24 til 48 timer efter, at æggestokkene har produceret en eller flere tilstrækkeligt modne follikler (æg, der er klar til løsning).
English: It must not be used in patients with tumours of the hypothalamus, pituitary gland, ovary, womb or breast.
Danish: Det må ikke anvendes til patienter med tumorer i hypothalamus, hypofysen, æggestokkene, livmoderen eller brystet.
English: What is the risk associated with Ovitrelle?
Danish: Hvilken risiko er der forbundet med Ovitrelle?
English: It can be used in women who are undergoing fertility treatment (such as in vitro fertilisation), and in women who are anovulatory (do not produce eggs) or oligo ovulatory (rarely produce eggs).
Danish: Det kan anvendes hos kvinder, der modtager fertilitetsbehandling (som f.eks. in vitro-befrugtning), og hos kvinder, der er anovulatoriske (ikke danner æg) eller oligo-ovulatoriske (sjældent danner æg).
English: Ovarian hyperstimulation syndrome occurs when the ovaries over respond to treatment, especially when medicines to trigger ovulation have been used.
Danish: Ovarielt hyperstimulationssyndrom opstår, når æggestokkene overreagerer på behandlingen, især når der er anvendt ægløsningsstimulerende lægemidler.
English: It must not be used in women with ovarian enlargement or cysts not due to polycystic ovarian disease, unexplained vaginal bleeding, or who have had an ectopic pregnancy (a pregnancy that develops outside the womb) in the previous three months.
Danish: Det må heller ikke anvendes til kvinder med forstørrede ovarier eller ovariecyster, der ikke skyldes polycystisk ovariesyndrom, med blødning fra skeden af ukendt årsag, eller som har haft en ekstrauterin graviditet (en graviditet uden for livmoderen) i de foregående tre måneder.
English: Because of its similarity to luteinising hormone (LH), Ovitrelle is also used to trigger ovulation.
Danish: Da Ovitrelle ligner luteiniserende hormon (LH), anvendes det også til at fremkalde æggeløsning.
English: In women undergoing fertility treatment, this is generally 24 to 48 hours after stopping treatment to stimulate the ovaries (such as a follicle stimulating hormone [FSH] or human menopausal gonadotrophin [hMG] preparation).
Danish: Hos kvinder i fertilitetsbehandling vil dette sædvanligvis sige 24 til 48 timer efter ophør af den forudgående æggestokstimulerende behandling (med follikelstimulerende hormon [FSH] eller humant menopausalt gonadotropin [hMG].
English: Why has Ovitrelle been approved?
Danish: Hvorfor blev Ovitrelle godkendt?
English: What is Ovitrelle?
Danish: Hvad er Ovitrelle?
English: Ovitrelle is used in women who have received treatment to stimulate their ovaries, to trigger ovulation (the release of eggs by the ovaries) and the development of a special structure on the ovary (the corpus luteum) that helps pregnancy.
Danish: Ovitrelle anvendes til kvinder, der er blevet behandlet med ovariestimulerende lægemidler, til at fremkalde ægløsning og udvikling af en særlig struktur på ovariet (corpus luteum), som medvirker til at gøre svangerskab muligt.
English: It is available as a powder and solvent to be made up into a solution for injection and as a solution in a pre-filled syringe or pre-filled pen.
Danish: Det leveres som et pulver med solvens, der blandes til en injektionsvæske (opløsning), og som en opløsning i en fyldt injektionssprøjte eller fyldt engangspen.
English: What is Ovitrelle used for?
Danish: Hvad anvendes Ovitrelle til?
English: What benefit has Ovitrelle shown during the studies?
Danish: Hvilken fordel viser undersøgelserne, at der er ved Ovitrelle?
English: How has Ovitrelle been studied?
Danish: Hvordan blev Ovitrelle undersøgt?
English: How is Ovitrelle used?
Danish: Hvordan anvendes Ovitrelle?
English: The choriogonadotropin alfa in Ovitrelle is produced by a method known as ‘recombinant DNA technology': it is made by a cell that has received a gene (DNA), which makes cell able to produce it.
Danish: Choriogonadotropin alfa i Ovitrelle fremstilles ved en metode, der kaldes ‘rekombinant DNA-teknik'.
English: How does Ovitrelle work?
Danish: Hvordan virker Ovitrelle?
English: This overview was last updated in September 2019.
Danish: Denne oversigt blev sidst ajourført i september 2019.
English: Gumbohatch was investigated in 5 laboratory and 3 field studies.
Danish: Gumbohatch blev undersøgt i fem laboratorie- og tre feltstudier.
English: Virulent means that the virus is capable of producing severe disease.
Danish: Virulent betyder, at virusset kan fremkalde alvorlig sygdom.
English: Further information on Gumbohatch can be found on the Agency's website: ema.europa.eu/medicines/veterinary/EPAR/gumbohatch.
Danish: Yderligere information om Gumbohatch findes på agenturets websted under: ema.europa.eu/medicines/veterinary/EPAR/gumbohatch.
English: Hands and equipment should be washed and disinfected after use of the vaccine.
Danish: Hænder og udstyr vaskes og desinficeres efter brug af vaccinen.
English: Studies have shown the start of protection to be from between 24 days of age and 28 days of age.
Danish: Studier har vist, at beskyttelsen indtræder mellem 24- og 28-dagesalderen.
English: The withdrawal period for meat and eggs from chickens treated with Gumbohatch is ‘zero' days, which means that there is no mandatory waiting time.
Danish: Tilbageholdelsestiden for kød og æg fra kyllinger, der behandles med Gumbohatch, er "nul" dage, hvilket vil sige, at der ikke er nogen påkrævet ventetid.
English: Protection against IBD starts from between 24 to 28 days of age and lasts up to 43 days of age.
Danish: Beskyttelsen mod IBD indtræder mellem 24- og 28-dagesalderen og varer op til 43-dagesalderen.
English: Gumbohatch is a vaccine.
Danish: Gumbohatch er en vaccine.
English: This loss of lymphocytes does not cause immunosuppression in the chickens.
Danish: Faldet i lymfocytter forårsager ikke immunsuppression hos kyllingerne.
English: In case of accidental self-injection, medical advice should be sought immediately and the package leaflet or label shown to the doctor.
Danish: Ved utilsigtet selvinjektion bør der straks søges lægehjælp, og indlægssedlen eller etiketten skal vises til lægen.
English: The European Medicines Agency decided that Gumbohatch's benefits are greater than its risks and it can be authorised for use in the EU.
Danish: Det Europæiske Lægemiddelagentur besluttede, at fordelene ved Gumbohatch opvejer risiciene, og at det kan godkendes til anvendelse i EU.
English: Vaccines work by preparing the immune system (the body's natural defences) to defend itself against a specific disease.
Danish: Vacciner virker ved at lære immunsystemet (kroppens naturlige forsvar), hvordan det skal forsvare sig mod en bestemt sygdom.
English: The start of protection depends on the initial maternal antibody level of the batch of chickens and even then will be different for individual chickens.
Danish: Hvornår beskyttelsen indtræder afhænger af det oprindelige niveau af maternelle antistoffer hos det pågældende parti kyllinger og vil selv da være forskelligt for de enkelte kyllinger.
English: It is also the time required after administration of a medicine before eggs may be used for human consumption.
Danish: Det er også den tid, der skal gå efter indgivelsen af et lægemiddel, før æggene kan anvendes til menneskeligt konsum.
English: When the chicken comes into contact with a similar IBD virus, these antibodies, together with other components of the chicken's immune system, will be able to fight the infection and help protect it against the disease.
Danish: Hvis kyllingen senere kommer i kontakt med et lignende IBD-virus, vil disse antistoffer sammen med andre komponenter i kyllingens immunsystem være i stand til at bekæmpe infektionen og hjælpe med at beskytte den mod sygdommen.
English: Other information about Gumbohatch
Danish: Andre oplysninger om Gumbohatch
English: The vaccine can be given to one-day-old chicks as a single injection under the skin or directly into 18day-old chicken eggs containing embryos (unhatched developing chicks).
Danish: Vaccinen kan gives til daggamle kyllinger som en enkelt injektion under huden eller direkte i 18 dage gamle æg med ikkeudklækkede fostre under udvikling.
English: For more information about using Gumbohatch, see the package leaflet or contact your veterinarian or pharmacist.
Danish: Hvis du ønsker flere oplysninger om anvendelsen af Gumbohatch, kan du læse indlægssedlen eller kontakte din dyrlæge eller dit apotek.
English: The most common side effect with Gumbohatch (which may affect more than 1 in 10 animals) is a fall in the number of lymphocytes (a type of white blood cell which is part of the chicken's immune system) in the bursa of Fabricius, followed by an increase and recovery of the bursa of Fabricius.
Danish: Den hyppigste bivirkning ved Gumbohatch (som kan forekomme hos mere end 1 ud af 10 dyr) er et fald i antallet af lymfocytter (en type hvide blodlegemer, som er en del af kyllingens immunsystem) i Bursa fabricii efterfulgt af en stigning og bedring i Bursa fabricii.
English: IBD, also known as Gumboro disease, is a highly contagious (spreads easily) viral infection of young chickens that reduces their immunity (body's ability to fight disease) and can lead to their death at 3 to 6 weeks of age.
Danish: IBD, også kendt som Gumboro-syge, er en meget smitsom virusinfektion hos unge kyllinger, som reducerer deres immunitet (kroppens evne til at bekæmpe sygdom) og kan føre til, at de dør i 3-6ugersalderen.
English: Signs of chickens infected with Gumboro disease include trembling, ruffled feathers, poor appetite, dehydration, diarrhoea, huddling and depression.
Danish: Tegn på, at kyllinger er inficeret med Gumboro-syge, omfatter rysten, pjusket fjerdragt, ringe appetit, dehydrering, diarré, dyr, der kryber sammen, og depression.
English: The vaccine reduces signs of the disease and damage to the bursa of Fabricius, an organ only present in birds which is part of their immune system.
Danish: Vaccinen reducerer sygdomstegnene og beskadigelsen af Bursa fabricii, som er et organ, der kun forekommer hos fugle og er en del af deres immunsystem.
English: When a chick or chicken egg is given the vaccine, the immune system recognises the weakened virus in the vaccine as ‘foreign' and makes its own antibodies against the virus.
Danish: Når en kylling eller et æg vaccineres, opfatter immunsystemet det svækkede virus i vaccinen som "fremmed" og danner selv antistoffer mod virusset.
English: Gumbohatch contains a live strain of IBD virus (strain 1052) that has been weakened so that it does not cause the disease.
Danish: Gumbohatch indeholder en levende stamme af IBD-virus (stamme 1052), som er blevet svækket, så den ikke forårsager sygdommen.
English: An overview of Gumbohatch and why it is authorised in the EU
Danish: En oversigt over Gumbohatch, og hvorfor det er godkendt i EU
English: Why is Gumbohatch authorised in the EU?
Danish: Hvorfor er Gumbohatch godkendt i EU?
English: What is Gumbohatch and what is it used for?
Danish: Hvad er Gumbohatch, og hvad anvendes det til?
English: After handling vaccinated birds or their litter, hands should be washed and disinfected because the virus is excreted by vaccinated birds for up to 3 weeks.
Danish: Hænderne skal vaskes og desinficeres efter håndtering af vaccinerede fjerkræ eller deres affald, da virusset udskilles af de vaccinerede fuglene i op til 3 uger.
English: Gumbohatch is available as a freeze dried powder (lyophilisate) and solvent to be made into a suspension for injection and can only be obtained with a prescription.
Danish: Gumbohatch fås som frysetørret pulver (lyofilisat) og solvens til injektionsvæske, suspension, og lægemidlet fås kun på recept.
English: Gumbohatch contains small amounts of weakened IBD virus attached to antibodies.
Danish: Gumbohatch indeholder små mængder af svækket IBD-virus bundet til antistoffer.
English: Gumbohatch received a marketing authorisation valid throughout the EU on 12 November 2019.
Danish: Gumbohatch modtog en markedsføringstilladelse med gyldighed i hele Den Europæiske Union den
English: The studies showed Gumbohatch to reduce clinical signs and damage to the bursa of Fabricius caused by very virulent (powerful) IBD virus infection, following vaccination of eggs or chicks.
Danish: Studierne viste, at Gumbohatch reducerede de kliniske tegn og beskadigelsen af Bursa fabricii forårsaget af en meget virulent IBD-virusinfektion efter vaccination af æg eller kyllinger.
English: What are the risks associated with Gumbohatch?
Danish: Hvilke risici er der forbundet med Gumbohatch?
English: Gumbohatch must not be used in flocks without maternal antibodies against IBD virus.
Danish: Gumbohatch må ikke anvendes i flokke uden maternelle antistoffer mod IBD-virus.
English: Gumbohatch is a vaccine used to protect broiler chickens (reared for meat) against infectious bursal disease (IBD) virus infection caused by a very virulent IBD virus.
Danish: Gumbohatch er en vaccine, der anvendes til beskyttelse af slagtekyllinger (opdrættet til kødproduktion) mod Infectious Bursal Disease Virus (infektiøs bursitis-virus) forårsaget af infektion med meget virulent (stærk) infektiøs bursitis-virus (IBD-virus).
English: The vaccine should be used only in flocks that are known to have maternal antibodies (transmitted from the mother) against IBD virus.
Danish: Vaccinen må kun anvendes i flokke med maternalt overførte antistoffer (overført fra moderen) mod IBD-virus.